Results 271 to 280 of about 116,783 (314)
Switchable Retargeting of Lentiviral Vectors Through a VSV-G-Binding Adapter Molecule. [PDF]
Zhuchkov VA +4 more
europepmc +1 more source
Summary Venetoclax (VEN)‐based therapies have improved the treatment of acute myeloid leukaemia (AML); however, the emergence of resistance remains a major limitation. Mutations in protein tyrosine phosphatase (PTP) non‐receptor type 11 (PTPN11) and FMS like tyrosine kinase 3 with internal tandem duplication (FLT3‐ITD) are common in resistant patients ...
Maximilian Fleischmann +12 more
wiley +1 more source
Abstract Background and Purpose D‐amino acid oxidase (DAO) has been developed as a chemogenetic tool, to precisely manipulate redox levels in tissues and cells by generating H2O2 in the presence of D‐amino acids. The enzyme's significant oxygen consumption during H2O2 production may influence cellular oxygen levels.
Wiebke Maurer +10 more
wiley +1 more source
Ex Vivo Gene and Cell Therapy in Hematopoietic Stem Cells. [PDF]
Petrova IO, Smirnikhina SA.
europepmc +1 more source
PSMD12, located on the frequently amplified 17q region in LUAD, is upregulated in tumors and associated with poor prognosis and advanced stage. Functional studies revealed that PSMD12 promotes cell proliferation and G2/M transition by inhibiting CDK1 ubiquitination and stabilizing CDK1.
Yuya Ono +14 more
wiley +1 more source
Combined effects of restriction factors and transduction adjuvants on lentiviral vector gene transfer efficacy. [PDF]
Dewannieux M +4 more
europepmc +1 more source
Developing and optimizing a biocompatible tauopathy model using extracellular vesicle-mediated gene delivery. [PDF]
Ghadami S, Dellinger K.
europepmc +1 more source
G2B: an optimized lentiviral vector with enhanced titer and β-globin expression for improved β-thalassemia gene therapy. [PDF]
Gao ZY +11 more
europepmc +1 more source
Prospects for Development and Commercialisation of Allogeneic CAR-Based Therapies for Autoimmune Disease. [PDF]
Osborne M, Maher J.
europepmc +1 more source

